{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:04:40Z","timestamp":1790305480044,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bioorg.2025.109263","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:51:42Z","timestamp":1763765502000},"page":"109263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["New 2-benzylideneamino-4,5-diphenylfuran-3\u2011carbonitrile derivatives and their benzylamino analogues: Synthesis, in vitro cytotoxicity, protein kinase inhibitory activity and in silico insights"],"prefix":"10.1016","volume":"168","author":[{"given":"Essam Eldin A.","family":"Osman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar Abd El-karim","family":"kassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed K.B.A.W.","family":"Farouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed R.","family":"Elnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed I.A.","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safinaz E-S.","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram H.","family":"Abd El-Haleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bioorg.2025.109263_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/1948-5956.100000e2","article-title":"History of cancer, ancient and modern treatment methods","volume":"1","author":"Sudhakar","year":"2009","journal-title":"J. Cancer Sci. & Therapy"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109263_bb0010","article-title":"Overview of FDA-approved anti cancer drugs used for targeted therapy","volume":"2","author":"Di Martino","year":"2015","journal-title":"WCRJ"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109263_bb0015","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1124\/jpet.105.084145","article-title":"Role of tyrosine kinase inhibitors in cancer therapy","volume":"315","author":"Arora","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109263_bb0020","article-title":"Imatinib: a breakthrough of targeted therapy in cancer","volume":"2014","author":"Iqbal","year":"2014","journal-title":"Chemotherapy Research And Practice"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109263_bb0025","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1517\/14728222.10.6.877","article-title":"Epidermal growth factor receptor as a major anticancer drug target","volume":"10","author":"Caponigro","year":"2006","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bioorg.2025.109263_bb0030","series-title":"Human Anatomy and Physiology I","author":"Cooper","year":"2015"},{"issue":"15","key":"10.1016\/j.bioorg.2025.109263_bb0035","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1242\/dev.091744","article-title":"Cdks, cyclins and CKIs: roles beyond cell cycle regulation","volume":"140","author":"Lim","year":"2013","journal-title":"Development"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109263_bb0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00018-002-8410-1","article-title":"Regulation of cyclin-Cdk activity in mammalian cells","volume":"59","author":"Obaya","year":"2002","journal-title":"Cellular and Molecular Life Sciences CMLS"},{"issue":"11","key":"10.1016\/j.bioorg.2025.109263_bb0045","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/ncb1109-1275","article-title":"Cyclin-dependent kinases: a family portrait","volume":"11","author":"Malumbres","year":"2009","journal-title":"Nat. Cell Biol."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109263_bb0050","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.tibs.2005.09.005","article-title":"Mammalian cyclin-dependent kinases","volume":"30","author":"Malumbres","year":"2005","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109263_bb0055","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/cancers7010179","article-title":"Targeting cyclin-dependent kinases in human cancers: from small molecules to peptide inhibitors","volume":"7","author":"Peyressatre","year":"2015","journal-title":"Cancers"},{"issue":"14","key":"10.1016\/j.bioorg.2025.109263_bb0060","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.2174\/1389557516666160321114917","article-title":"Review on EGFR inhibitors: critical updates","volume":"16","author":"Singh","year":"2016","journal-title":"Mini-Rev. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109263_bb0065","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1158\/1535-7163.MCT-10-0324","article-title":"Dinaciclib (SCH 727965), a novel and potent cyclin-dependent kinase inhibitor","volume":"9","author":"Parry","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2025.109263_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107413","article-title":"Molecular docking approach for the design and synthesis of new pyrazolopyrimidine analogs of roscovitine as potential CDK2 inhibitors endowed with pronounced anticancer activity","volume":"147","author":"Hamed","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109263_bb0075","doi-asserted-by":"crossref","unstructured":"N.S. Saleh, et al., 6, 7-Dimethoxy-2-methyl-4-substituted quinazolines: design, synthesis, EGFR inhibitory activity, in vitro cytotoxicity, and in silico studies, Eur. J. Med. Chem. 290 (2025) 117502.","DOI":"10.1016\/j.ejmech.2025.117502"},{"key":"10.1016\/j.bioorg.2025.109263_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103726","article-title":"Design and synthesis of some new 2, 4, 6-trisubstituted quinazoline EGFR inhibitors as targeted anticancer agents","volume":"98","author":"Allam","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109263_bb0085","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejmech.2016.04.054","article-title":"Chiral 6-aryl-furo [2, 3-d] pyrimidin-4-amines as EGFR inhibitors","volume":"119","author":"Han","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109263_bb0090","doi-asserted-by":"crossref","first-page":"94","DOI":"10.32947\/ajps.v25i1.1132","article-title":"Design, molecular docking, synthesis, characterization and preliminary evaluation of novel 1, 3, 4-Oxadiazole derivatives as cyclin-dependent kinase 2 inhibitors","volume":"25","author":"Ali","year":"2025","journal-title":"Al Mustansiriyah Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.bioorg.2025.109263_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104586","article-title":"Furan-2-carboxamide derivative, a novel microtubule stabilizing agent induces mitotic arrest and potentiates apoptosis in cancer cells","volume":"108","author":"Shwetha","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109263_bb0100","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1134\/S1070363219030204","article-title":"Design, synthesis and anticancer evaluation of novel furan sulphonamide derivatives","volume":"89","author":"Purna Chander Rao","year":"2019","journal-title":"Russ. J. Gen. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109263_bb0105","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3390\/molecules24091751","article-title":"4, 5-Diaryl 3 (2H) furanones: anti-inflammatory activity and influence on cancer growth","volume":"24","author":"Semenok","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109263_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106099","article-title":"Design and synthesis of some new 6-bromo-2-(pyridin-3-yl)-4-substituted quinazolines as multi tyrosine kinase inhibitors","volume":"128","author":"Farouk","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109263_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133851","article-title":"Some 2-(4-bromophenoxymethyl)-6-iodo-3-substituted quinazolin-4 (3H) ones: synthesis, cytotoxic activity, EGFR inhibition and molecular docking","volume":"1269","author":"Abbas","year":"2022","journal-title":"J. Mol. Struct."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109263_bb0120","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1016\/j.bmc.2009.01.016","article-title":"Synthesis of 2-(5-((5-(4-chlorophenyl) furan-2-yl) methylene)-4-oxo-2-thioxothiazolidin-3-yl) acetic acid derivatives and evaluation of their cytotoxicity and induction of apoptosis in human leukemia cells","volume":"17","author":"Chandrappa","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2025.109263_bb0125","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1016\/j.bmcl.2009.05.052","article-title":"Discovery of 3-aryl-5-aryl-1, 2, 4-oxadiazoles as a new series of apoptosis inducers. 2. Identification of more aqueous soluble analogs as potential anticancer agents","volume":"19","author":"Kemnitzer","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109263_bb0130","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1021\/jm901798e","article-title":"Discovery and SAR of thiazolidine-2, 4-dione analogues as insulin-like growth factor-1 receptor (IGF-1R) inhibitors via hierarchical virtual screening","volume":"53","author":"Liu","year":"2010","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109263_bb0135","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.3390\/molecules16064897","article-title":"Synthesis and in vitro protein tyrosine kinase inhibitory activity of furan-2-yl (phenyl) methanone derivatives","volume":"16","author":"Zheng","year":"2011","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109263_bb0140","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/cber.19660990340","article-title":"Heterocyclen aus CH-aciden Nitrilen, IX. \u00dcber die Reaktion von \u03b1-Hydroxy-ketonen mit Malodinitril","volume":"99","author":"Gewald","year":"1966","journal-title":"Chem. Ber."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109263_bb0145","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/jhet.5570330671","article-title":"First synthesis of 4H-furo [3, 2-f] pyrrolo [1, 2-a][1, 4] diazepines","volume":"33","author":"Feng","year":"1996","journal-title":"J. Heterocyclic Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109263_bb0150","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1021\/jo01345a056","article-title":"Nucleophilic displacements of activated fluorine in aromatic compounds","volume":"31","author":"Bader","year":"1966","journal-title":"J. Organomet. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2025.109263_bb0155","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.carres.2010.06.005","article-title":"A new chitosan biopolymer derivative as metal-complexing agent: synthesis, characterization, and metal (II) ion adsorption studies","volume":"345","author":"Krishnapriya","year":"2010","journal-title":"Carbohydr. Res."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109263_bb0160","doi-asserted-by":"crossref","first-page":"216","DOI":"10.25004\/IJPSDR.2010.020311","article-title":"Synthesis and biological evaluation of some sulfonamide Schiff's bases","volume":"2","author":"Singh","year":"2010","journal-title":"International Journal of Pharmaceutical Sciences and Drug Research"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109263_bb0165","first-page":"1000191","article-title":"Synthesis of novel series of phthalazine derivatives with antibacterial and antifungal evaluation","volume":"5","author":"El-Hashash","year":"2014","journal-title":"Journal of Chemical Engineering And Process Technology"},{"key":"10.1016\/j.bioorg.2025.109263_bb0170","series-title":"Schiff bases and their metallic derivatives: highly versatile molecules with biological and Abiological perspective, in stability and applications of coordination compounds, a.N. Srivastva, editor","author":"Khan","year":"2019"},{"issue":"20","key":"10.1016\/j.bioorg.2025.109263_bb0175","doi-asserted-by":"crossref","first-page":"11230","DOI":"10.1039\/C8RA00357B","article-title":"Intramolecular hydrogen bond directed stable conformations of benzoyl phenyl oxalamides: unambiguous evidence from extensive NMR studies and DFT-based computations","volume":"8","author":"Dhanishta","year":"2018","journal-title":"RSC Adv."},{"issue":"17","key":"10.1016\/j.bioorg.2025.109263_bb0180","doi-asserted-by":"crossref","first-page":"10070","DOI":"10.1039\/C6RA26779C","article-title":"Conformational stabilization of isatin Schiff bases \u2013 biologically active chemical probes","volume":"7","author":"Smirnov","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.109263_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106758","article-title":"New Schiff bases derived from dimethylpyridine-1,2,4-triazole hybrid as cytotoxic agents targeting gastrointestinal cancers: design, synthesis, biological evaluation and molecular docking studies","volume":"139","author":"Strzelecka","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109263_bb0190","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1021\/acsmedchemlett.4c00438","article-title":"Furan- and Furopyrimidine-based derivatives: synthesis, VEGFR-2 inhibition, and in vitro cytotoxicity","volume":"15","author":"Abd El-Haleem","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109263_bb0195","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1021\/jo01360a019","article-title":"Reduction of Schiff bases with sodium borohydride","volume":"22","author":"Billman","year":"1957","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2025.109263_bb0200","series-title":"A Cleaner Approach for Reduction of some Symmetric Diimines Using NaBH4","author":"Aghera","year":"2009"},{"key":"10.1016\/j.bioorg.2025.109263_bb0205","series-title":"Sodium Borohydride Reduction of Vanillin: A Low Solvent Synthesis of Vanillyl Alcohol","author":"Lecher","year":"2007"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109263_bb0210","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/carcin\/bgr008","article-title":"6, 7, 4\u2032-trihydroxyisoflavone inhibits HCT-116 human colon cancer cell proliferation by targeting CDK1 and CDK2","volume":"32","author":"Lee","year":"2011","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109263_bb0215","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.canlet.2004.04.034","article-title":"Expression of epidermal growth factor-receptor related protein (ERRP) in human colorectal carcinogenesis","volume":"213","author":"Jaszewski","year":"2004","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109263_bb0220","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13046-022-02389-z","article-title":"Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer","volume":"41","author":"Yang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109263_bb0225","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s13046-019-1497-0","article-title":"Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression","volume":"38","author":"Napolitano","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109263_bb0230","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/gut.53.1.123","article-title":"Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferon \u03b1","volume":"53","author":"Yang","year":"2004","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109263_bb0235","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1158\/1535-7163.MCT-06-0055","article-title":"Sequence-dependent inhibition of human colon cancer cell growth and of prosurvival pathways by oxaliplatin in combination with ZD6474 (Zactima), an inhibitor of VEGFR and EGFR tyrosine kinases","volume":"5","author":"Troiani","year":"2006","journal-title":"Mol. Cancer Ther."},{"issue":"24","key":"10.1016\/j.bioorg.2025.109263_bb0240","doi-asserted-by":"crossref","first-page":"17505","DOI":"10.3390\/ijms242417505","article-title":"Polyphenols enhance the anticancer effect of \u03b2-Lapachone in Oxaliplatin-resistant HCT116 colorectal Cancer cells","volume":"24","author":"Jung","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109263_bb0245","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1158\/1940-6207.CAPR-13-0387","article-title":"Curcumin suppresses proliferation of colon cancer cells by targeting CDK2","volume":"7","author":"Lim","year":"2014","journal-title":"Cancer Prev. Res."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109263_bb0250","first-page":"233","article-title":"Cdk2\/cdc2 expression in colon carcinogenesis and effects of cdk2\/cdc2 inhibitor in colon cancer cells","volume":"13","author":"Yamamoto","year":"1998","journal-title":"Int. J. Oncol."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109263_bb0255","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1101\/gr.152322.112","article-title":"Next-generation sequencing of paired tyrosine kinase inhibitor-sensitive and-resistant EGFR mutant lung cancer cell lines identifies spectrum of DNA changes associated with drug resistance","volume":"23","author":"Jia","year":"2013","journal-title":"Genome Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109263_bb0275","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.109263_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106496","article-title":"Development of certain aminoquinazoline scaffolds as potential multitarget anticancer agents with apoptotic and anti-proliferative effects: design, synthesis and biological evaluation","volume":"135","author":"Amin","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109263_bb0285","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0003-2697(81)90281-5","article-title":"\u201cWestern blotting\u201d: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein a","volume":"112","author":"Burnette","year":"1981","journal-title":"Anal. Biochem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825011435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825011435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T09:53:08Z","timestamp":1767693188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825011435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":54,"alternative-id":["S0045206825011435"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109263","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New 2-benzylideneamino-4,5-diphenylfuran-3\u2011carbonitrile derivatives and their benzylamino analogues: Synthesis, in vitro cytotoxicity, protein kinase inhibitory activity and in silico insights","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109263","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109263"}}